Compared to the remaining two groups, participants in the dabigatran group were more likely to be male, younger, and heavier; have better renal function reflected by lower CRE and cystatin C and higher GFR estimated by different renal function equations; have fewer congestive heart failure. The gene discussed is CST3; the disease is congestive heart failure.